Ilex Medical Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	175.59	177.25	148.38	200.96	259.23
Short-Term Investments	-	25.87	41.25	2.74	-
Trading Asset Securities	56.05	33.76	27.48	22	25.52
Cash & Short-Term Investments	231.64	236.88	217.11	225.7	284.75
Cash Growth	-2.21%	9.11%	-3.81%	-20.74%	62.02%
Accounts Receivable	265.87	249.37	286.25	248.26	219.99
Other Receivables	7.06	17.56	15.57	3.04	3.73
Receivables	272.93	266.93	301.82	251.3	223.72
Inventory	194.21	157.89	159.68	145.8	116.32
Other Current Assets	24.89	56.77	7.39	12.02	6.93
Total Current Assets	723.66	718.47	686.01	634.83	631.72
Property, Plant & Equipment	147.22	155.46	160.91	145.28	151.41
Long-Term Investments	54.51	53.71	57.95	72.66	32.1
Goodwill	7.01	7.01	7.01	7.01	-
Other Intangible Assets	11.95	17.08	21.27	25.06	25.87
Long-Term Accounts Receivable	-	34.91	28.51	5.73	3.75
Long-Term Deferred Tax Assets	5.77	7.42	8.51	6.35	6.35
Long-Term Deferred Charges	-	-	-	0.04	0.08
Other Long-Term Assets	42.61	0.01	45.95	2.23	23.8
Total Assets	992.74	994.07	1,016	899.18	875.07
Accounts Payable	140.79	120.44	172.11	142.32	124.39
Current Portion of Long-Term Debt	-	0.31	0.41	0.56	1.13
Current Portion of Leases	13.76	12.22	11.47	12.28	11.96
Current Income Taxes Payable	7.4	4.5	1.4	2.22	40.39
Other Current Liabilities	93.44	130.4	93.15	68.45	62.23
Total Current Liabilities	255.39	267.87	278.54	225.83	240.11
Long-Term Debt	-	-	0.31	0.73	1.29
Long-Term Leases	32.83	38.81	36.07	37.99	44.36
Long-Term Unearned Revenue	8.17	25.28	60.33	4.11	-
Pension & Post-Retirement Benefits	0.68	0.96	1.63	-	-
Long-Term Deferred Tax Liabilities	2.41	2.55	2.94	3.15	6.72
Other Long-Term Liabilities	8.54	12.12	12.77	14.28	7.02
Total Liabilities	308.02	347.58	392.61	286.08	299.49
Common Stock	12.48	12.48	12.48	12.48	12.48
Additional Paid-In Capital	150.5	150.5	150.5	150.5	150.5
Retained Earnings	610.8	568.58	544.92	515.41	472.39
Treasury Stock	-9.2	-9.2	-9.2	-3.49	-
Comprehensive Income & Other	-79.85	-75.86	-75.19	-61.79	-59.79
Total Common Equity	684.71	646.49	623.51	613.1	575.57
Shareholders' Equity	684.71	646.49	623.51	613.1	575.57
Total Liabilities & Equity	992.74	994.07	1,016	899.18	875.07
Total Debt	46.6	51.35	48.27	51.55	58.74
Net Cash (Debt)	185.04	185.53	168.84	174.15	226.02
Net Cash Growth	-0.27%	9.88%	-3.04%	-22.95%	107.33%
Net Cash Per Share	16.55	16.58	15.09	15.44	20.04
Filing Date Shares Outstanding	11.16	11.19	11.28	11.28	11.28
Total Common Shares Outstanding	11.16	11.19	11.19	11.25	11.28
Working Capital	468.27	450.6	407.47	409	391.61
Book Value Per Share	61.37	57.78	55.73	54.52	51.02
Tangible Book Value	665.76	622.4	595.24	581.04	549.7
Tangible Book Value Per Share	59.67	55.63	53.20	51.67	48.73
Land	-	0.06	0.06	0.06	0.06
Machinery	-	254.19	244.49	212.94	193.36
Leasehold Improvements	-	17.78	25.19	24.04	25.51

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.